Group 6 Copy 105
-1
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    A Bird's-eye View of Frog Habitats: Using a Drone to Survey Wetlands

    I study vulnerable frog species that inhabit human-constructed wetlands in the Grand River Grasslands of...

    Are cryptic characteristics preventing the protection of two similar Sphingidae moths?

    This project is aimed at understanding the morphological differences between two species of Sphingidae...

    Probiotics for plants? Fighting insects by boosting corn immune systems

    Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

    Backer Badge Funded

    A biology project funded by 47 people